U.S. Dengue Treatment Market to 2032
Overview
The U.S. Dengue Treatment Market is expected to reach a 130.44 USD Million by 2032 and is projected to grow at a CAGR of 11.23% from 2025 to 2032.
Revenue, 2024 (USD Million)
61.19
Forecast, 2032 (USD Million)
130.44
CAGR, 2024 - 2032
11.23%
Report Coverage
U.S.
U.S. Dengue Treatment Market 2018-2032 USD Million
U.S. Dengue Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 61.19 USD Million
- Projected Market Size (2032): 130.44 USD Million
- CAGR (2025-2032): 11.23%
Key Findings of U.S. Dengue Treatment Market
- The U.S. Dengue Treatment Market was valued at 61.19 USD Million in 2024.
- The U.S. Dengue Treatment Market is likely to grow at a CAGR of 11.23% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription in Mode of Purchase Segment accounted for the largest share of the market with a revenue of 50.74 USD Million
- The fastest growing segment Home Healthcare in End User Segment grew Fastest with a CAGR of 12.30% during the forecast period from 2024 to 2032.
U.S. Dengue Treatment Market Scope
U.S. Dengue Treatment Market Segmentation & Scope
Strains
- DENV-2
- DENV-3
- DENV-1
- Others
- DENV-4
Route of Administration
- Oral
- Parenteral
Severity
- Severe Dengue
- Mild to Moderate Dengue
Type
- Acetaminophen
- Vaccines
Mode of Purchase
- Over-The-Counter (OTC)
- Prescription
Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
End User
- Others
- Home Healthcare
- Hospital
- Specialty Clinics
Age
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
U.S. Dengue Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 61.19 USD Million |
| Market Value in 2032 | 130.44 USD Million |
| CAGR (2025-2032) | 11.23% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Strains,Route of Administration,Severity,Type,Mode of Purchase,Distribution Channel,End User,Age,Gender |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 61.19 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 61.19 USD Million in 2024.
Segments and Scope
-
U.S. Dengue Treatment Market to 2032, By Strains
- DENV-2 is the largest segment in U.S. Dengue Treatment Market to 2032 with a revenue of 20.33 USD Million in the year 2024.
- DENV-1 is the Fastest growing segment in U.S. Dengue Treatment Market to 2032 with a Growth rate of 10.94 % in forecast period 2025-2032.
-
U.S. Dengue Treatment Market to 2032, By Route of Administration
- Parenteral is the largest segment in U.S. Dengue Treatment Market to 2032 with a revenue of 50.48 USD Million in the year 2024.
- Parenteral is the Fastest growing segment in U.S. Dengue Treatment Market to 2032 with a Growth rate of 11.36 % in forecast period 2025-2032.
-
U.S. Dengue Treatment Market to 2032, By Severity
- Mild to Moderate Dengue is the largest segment in U.S. Dengue Treatment Market to 2032 with a revenue of 36.56 USD Million in the year 2024.
- Mild to Moderate Dengue is the Fastest growing segment in U.S. Dengue Treatment Market to 2032 with a Growth rate of 11.63 % in forecast period 2025-2032.
-
U.S. Dengue Treatment Market to 2032, By Type
- Vaccines is the largest segment in U.S. Dengue Treatment Market to 2032 with a revenue of 42.69 USD Million in the year 2024.
- Vaccines is the Fastest growing segment in U.S. Dengue Treatment Market to 2032 with a Growth rate of 12.20 % in forecast period 2025-2032.
-
U.S. Dengue Treatment Market to 2032, By Mode of Purchase
- Prescription is the largest segment in U.S. Dengue Treatment Market to 2032 with a revenue of 50.74 USD Million in the year 2024.
- Prescription is the Fastest growing segment in U.S. Dengue Treatment Market to 2032 with a Growth rate of 11.36 % in forecast period 2025-2032.
-
U.S. Dengue Treatment Market to 2032, By Distribution Channel
- Retail Pharmacies is the largest segment in U.S. Dengue Treatment Market to 2032 with a revenue of 31.43 USD Million in the year 2024.
- Online Pharmacies is the Fastest growing segment in U.S. Dengue Treatment Market to 2032 with a Growth rate of 11.38 % in forecast period 2025-2032.
-
U.S. Dengue Treatment Market to 2032, By End User
- Hospital is the largest segment in U.S. Dengue Treatment Market to 2032 with a revenue of 34.69 USD Million in the year 2024.
- Home Healthcare is the Fastest growing segment in U.S. Dengue Treatment Market to 2032 with a Growth rate of 11.53 % in forecast period 2025-2032.
-
U.S. Dengue Treatment Market to 2032, By Age
- Adult is the largest segment in U.S. Dengue Treatment Market to 2032 with a revenue of 34.77 USD Million in the year 2024.
- Pediatric is the Fastest growing segment in U.S. Dengue Treatment Market to 2032 with a Growth rate of 10.82 % in forecast period 2025-2032.
-
U.S. Dengue Treatment Market to 2032, By Gender
- Male is the largest segment in U.S. Dengue Treatment Market to 2032 with a revenue of 43.30 USD Million in the year 2024.
- Male is the Fastest growing segment in U.S. Dengue Treatment Market to 2032 with a Growth rate of 11.50 % in forecast period 2025-2032.
U.S. Dengue Treatment Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Takeda Pharmaceutical Company Limited | |||
| Sanofi | |||
| GSK plc. | |||
U.S. Dengue Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
U.S. Dengue Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Dengue Treatment Market is segmented based on Segmentation Strains,Route of Administration,Severity,Type,Mode of Purchase,Distribution Channel,End User,Age,Gender.
U.S. Dengue Treatment Market was valued at USD 61.19(Revenue in USD Million) in 2022.
U.S. Dengue Treatment Market is projected to grow at a CAGR of 11.23% during the forecast period of 2024 to 2032.
The Prescription segment is expected to dominate the U.S. Dengue Treatment Market, holding a largest market share of 50.74 USD Million in 2024
U.S. Dengue Treatment Market Scope
U.S. Dengue Treatment Market Segmentation & Scope
Strains
- DENV-2
- DENV-3
- DENV-1
- Others
- DENV-4
Route of Administration
- Oral
- Parenteral
Severity
- Severe Dengue
- Mild to Moderate Dengue
Type
- Acetaminophen
- Vaccines
Mode of Purchase
- Over-The-Counter (OTC)
- Prescription
Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
End User
- Others
- Home Healthcare
- Hospital
- Specialty Clinics
Age
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Frequently Asked Questions
The U.S. Dengue Treatment Market is segmented based on Segmentation Strains,Route of Administration,Severity,Type,Mode of Purchase,Distribution Channel,End User,Age,Gender.
U.S. Dengue Treatment Market was valued at USD 61.19(Revenue in USD Million) in 2022.
U.S. Dengue Treatment Market is projected to grow at a CAGR of 11.23% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Dengue Treatment Market for final year is USD 130.44 (USD Million).
U.S. Dengue Treatment Market Company Profiling
Frequently Asked Questions
The U.S. Dengue Treatment Market is segmented based on Segmentation Strains,Route of Administration,Severity,Type,Mode of Purchase,Distribution Channel,End User,Age,Gender.
U.S. Dengue Treatment Market was valued at USD 61.19(Revenue in USD Million) in 2022.
U.S. Dengue Treatment Market is projected to grow at a CAGR of 11.23% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Dengue Treatment Market for final year is USD 130.44 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.